EarningsQ3 2024 Earnings Report

BioMarin Pharmaceutical (BMRN) Q3 2024 Earnings Report

0 Followers

MX:BMRN Q3 2024 EPS Results

Actual EPS$9.90

Consensus EPS$9.56

Beat/MissBeat by +$0.34

One Year Ago EPS$3.78

Actual Revenue$13.37B

Expected Revenue$12.67B

Beat/MissBeat by +$701.19M

YoY Revenue Growth+26.69%

QuarterQ3 2024

Date10/29/2024

TimeAfter Close

Conference CallTuesday, October 29, 2024

MX:BMRN Upcoming Earnings

BioMarin Pharmaceutical's next earnings date is estimated for November 3, 2026, based on past reporting schedules.

MX:BMRN Q3 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 03, 2026	2026 (Q3)	23.98 / -	-2.881	―
Aug 06, 2026	2026 (Q2)	17.05 / 21.61	22.146	-2.44% (-0.54)
May 04, 2026	2026 (Q1)	12.46 / 13.68	17.104	-20.00% (-3.42)
Feb 23, 2026	2025 (Q4)	3.04 / -4.32	11.523	-137.50% (-15.84)
Oct 27, 2025	2025 (Q3)	-5.04 / -2.88	9.903	-129.09% (-12.78)
Aug 04, 2025	2025 (Q2)	15.50 / 22.15	9.903	123.64% (+12.24)
May 01, 2025	2025 (Q1)	12.86 / 17.10	8.282	106.52% (+8.82)
Feb 19, 2025	2024 (Q4)	9.61 / 11.52	1.981	481.82% (+9.54)
Oct 29, 2024	2024 (Q3)	9.56 / 9.90	3.781	161.90% (+6.12)
Aug 05, 2024	2024 (Q2)	6.45 / 9.90	5.221	89.66% (+4.68)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed